相关实验视频

Updated: May 25, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

推进癌症数据收集:ICD-11在欧洲瘤和癌症注册表中的实施

Maciej Trojanowski¹, Irmina Maria Michalek², Anna Kubiak¹

¹Greater Poland Cancer Registry Greater Poland Cancer Centre Poznan Poland.

International journal of medical informatics

|February 25, 2025

概括

国际疾病分类第11版 (ICD-11) 提供了先进的癌症编码,但需要改进,以便无地融入欧洲癌症登记册. 从ICD-10过渡需要培训和更好的验证工具来准确收集数据.

科学领域:

医疗信息学医疗信息学
瘤学数据标准瘤学数据标准
公共卫生监督公共卫生监督

背景情况:

国际疾病分类 (ICD) 对于全球医疗数据标准化至关重要.
新的ICD-11新瘤章节承诺在欧洲加强癌症数据收集.
从已建立的ICD-10过渡到ICD-11,在癌症登记方面面临重大实施挑战.

研究的目的:

评估在欧洲癌症登记册和医疗保健系统中实施ICD-11的可行性.
检查ICD-11的瘤编码结构及其在癌症数据收集中取代ICD-10的潜力.

主要方法:

分析ICD-11第2章 (新生体),重点是协调前后编码.
针对各种癌症属性 (部位,形态,等级,阶段等) 的ICD-10到ICD-11代码的全面映射. ) 的情况.
审查编码验证工具及其在注册表和医院IT系统中的应用.

主要成果:

通过后协调,ICD-11可实现更精确的瘤编码,捕获详细的瘤亚型和预后因素.
在ICD-11分级和分阶段系统中观察到的不一致性允许无效的组合.
地图绘制揭示了差距,特别是在从ICD-10过渡时表示复杂的癌症诊断时.

结论:

ICD-11的复杂性和缺乏验证机制,对癌症注册机构立即采用提出了挑战.
成功过渡需要广泛的培训,增强的绘图工具,以及对准确数据的强大验证系统.
为了完全采用ICD-11,对ICD-11的进一步改进至关重要,尽管癌症注册表可以支持过渡过程.

关键词:

癌症登记处的癌症登记处数据收集数据收集数据处理数据处理.医疗保健政策医疗保健政策在ICD-10中,它被命名为ICD-10.在ICD-11中,它被列为ICD-11.国际疾病预防控制局-O

更多相关视频

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Data Collection II

Data Collection II

The nursing history captures and records the patient's health status, so that a care plan evolves to meet the patient's individual needs. The nursing health history is a part of the initial assessment. A comprehensive history covers all health dimensions and plays a significant role in the assessment process. A comprehensive history includes the patient's biographical information, reasons for seeking health care, expectations, present and past health history, medications, and...

Data Collection I

Data Collection I

Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...